Scientists hunt for hidden signals in muscle cells that could explain insulin resistance

NCT ID NCT07516509

Recruiting now Knowledge-focused Sponsor: AdventHealth Translational Research Institute Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Aug 13, 2026 · Updated 2 times

Summary

This study aims to find new signs in muscle cells that help explain why the body stops responding well to insulin, a condition called insulin resistance. Researchers will study 36 adults aged 30 to 65, including lean individuals and those with obesity, using advanced cell analysis and fitness tests. The goal is to better understand the biology behind insulin resistance, not to test a new drug or treatment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could reveal new biological markers for insulin resistance, potentially guiding future treatments.
What could go wrong: This is an early observational study with only 36 participants, so findings may not apply broadly. It does not test a treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INSULIN RESISTANCE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Insulin Resistance

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

INSULIN RESISTANCE

Contacts and locations

Locations

AdventHealth Translational Research Institute
RECRUITING

Orlando, Florida, 32804, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.